All Stories

  1. Liquid Biopsy in Primary CNS Tumors: Bridging Biology, Technology, and Clinical Care
  2. Founder Variants in the Mexican Population: A Systematic Review
  3. Germline Genetic Variants in Cancer Predisposition Genes in Patients From Latin America and the Caribbean
  4. Increased amounts of cell-free DNA released from a culture with a high content of cancer stem cells
  5. Somatic Landscape of Oncogenic Variants Across the Main Cancer Subtypes in Latin America: A Narrative Review
  6. TP53 oncogenic variants as prognostic factors in individuals with glioblastoma: a systematic review and meta-analysis
  7. The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer
  8. NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review
  9. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
  10. ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma
  11. Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications
  12. Hereditary gastric cancer literature review
  13. A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma
  14. Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient
  15. Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism
  16. The role of extracellular DNA (exDNA) in cellular processes
  17. Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma
  18. Investigation of HER-2 status, treatment response and survival analysis in cervical cancer patients
  19. High-Dose Methotrexate, A Tried-and-True Treatment with Genomic Delicacies: A Case Report
  20. A combination of inhibitors of glycolysis, glutaminolysis and de�novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
  21. Growth inhibition and transcriptional effects of ribavirin in lymphoma
  22. Epigenetic treatment of metastasis with hydralazine and valproic acid
  23. Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma
  24. Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
  25. Características ultrasonográficas, histopatológicas y genéticas del melanoma uveal en población mexicana mestiza ☆
  26. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening
  27. Single nucleotide polymorphisms associated with nonsyndromic cryptorchidism in Mexican patients
  28. Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer
  29. Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model
  30. Viral inhibitors of NKG2D ligands for tumor surveillance
  31. Ribavirin as a tri-targeted antitumor repositioned drug
  32. DNA methyltransferases 3a and 3b are differentially expressed in the early stages of a rat liver carcinogenesis model
  33. Hydralazine–valproate: a repositioned drug combination for the epigenetic therapy of cancer
  34. The reduction of Calpain-10 expression is associated with risk polymorphisms in obese children
  35. Neuroendocrine Marker Expression in Cervical Carcinomas of Non-Small Cell Type